153 related articles for article (PubMed ID: 11576999)
1. p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator.
Abeysinghe RD; Greene BT; Haynes R; Willingham MC; Turner J; Planalp RP; Brechbiel MW; Torti FM; Torti SV
Carcinogenesis; 2001 Oct; 22(10):1607-14. PubMed ID: 11576999
[TBL] [Abstract][Full Text] [Related]
2. Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator.
Zhao R; Planalp RP; Ma R; Greene BT; Jones BT; Brechbiel MW; Torti FM; Torti SV
Biochem Pharmacol; 2004 May; 67(9):1677-88. PubMed ID: 15081867
[TBL] [Abstract][Full Text] [Related]
3. Activation of caspase pathways during iron chelator-mediated apoptosis.
Greene BT; Thorburn J; Willingham MC; Thorburn A; Planalp RP; Brechbiel MW; Jennings-Gee J; Wilkinson J; Torti FM; Torti SV
J Biol Chem; 2002 Jul; 277(28):25568-75. PubMed ID: 11980894
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
[TBL] [Abstract][Full Text] [Related]
5. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
Mahyar-Roemer M; Roemer K
Oncogene; 2001 Jun; 20(26):3387-98. PubMed ID: 11423989
[TBL] [Abstract][Full Text] [Related]
6. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
Baptiste N; Friedlander P; Chen X; Prives C
Oncogene; 2002 Jan; 21(1):9-21. PubMed ID: 11791172
[TBL] [Abstract][Full Text] [Related]
7. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
Piovesan B; Pennell N; Berinstein NL
Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
[TBL] [Abstract][Full Text] [Related]
8. [Effects of p21WAF1/CIP1 gene introduction on a human lung cancer cell line with p53 mutation].
Zhuo Y; Zhang B; Li T; Wang H; Li S; Hou L; Wu B
Zhonghua Bing Li Xue Za Zhi; 1999 Aug; 28(4):272-6. PubMed ID: 11869537
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
Ramondetta L; Mills GB; Burke TW; Wolf JK
Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
[TBL] [Abstract][Full Text] [Related]
10. Influence of p53 and p21(WAF1) expression on sensitivity of cancer cells to cladribine.
Galmarini CM; Voorzanger N; Falette N; Jordheim L; Cros E; Puisieux A; Dumontet C
Biochem Pharmacol; 2003 Jan; 65(1):121-9. PubMed ID: 12473386
[TBL] [Abstract][Full Text] [Related]
11. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
[TBL] [Abstract][Full Text] [Related]
12. Depletion of endogenous nitric oxide enhances cisplatin-induced apoptosis in a p53-dependent manner in melanoma cell lines.
Tang CH; Grimm EA
J Biol Chem; 2004 Jan; 279(1):288-98. PubMed ID: 14576150
[TBL] [Abstract][Full Text] [Related]
13. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
15. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.
Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL
Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
Ling YH; Liebes L; Jiang JD; Holland JF; Elliott PJ; Adams J; Muggia FM; Perez-Soler R
Clin Cancer Res; 2003 Mar; 9(3):1145-54. PubMed ID: 12631620
[TBL] [Abstract][Full Text] [Related]
17. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
Bacus SS; Gudkov AV; Lowe M; Lyass L; Yung Y; Komarov AP; Keyomarsi K; Yarden Y; Seger R
Oncogene; 2001 Jan; 20(2):147-55. PubMed ID: 11313944
[TBL] [Abstract][Full Text] [Related]
18. The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1.
Liang SX; Richardson DR
Carcinogenesis; 2003 Oct; 24(10):1601-14. PubMed ID: 12869419
[TBL] [Abstract][Full Text] [Related]
19. Mismatch repair and p53 independently affect sensitivity to N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea.
Aquilina G; Ceccotti S; Martinelli S; Soddu S; Crescenzi M; Branch P; Karran P; Bignami M
Clin Cancer Res; 2000 Feb; 6(2):671-80. PubMed ID: 10690553
[TBL] [Abstract][Full Text] [Related]
20. Enhanced sensitivity to cis-diamminedichloroplatinum(II) of a human carcinoma cell line with mutated p53 gene by cyclin-dependent kinase inhibitor p21(WAF1) expression.
Satou M; Aizawa S; Hayakari M; Ookawa K; Tsuchida S
Cancer Sci; 2003 Mar; 94(3):286-91. PubMed ID: 12824923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
